Business Health India Latest Stories World

iNCOVACC, world’s first nasal Covid-19 vaccine manufactured by Bharat Biotech to receive both primary series and Heterologous booster approval

Hyderabad based biotechnology company Bharat Biotech has launched the world’s first nasal Covid-19 vaccine. According to a Tweet shared by Bharat Biotech, iNCOVACC recently received approval under Restricted Use in Emergency Situation for ages 18 and above for heterologous booster doses

According to Bharat Biotech, iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19. It has two key attributes

  • An intranasal vaccine stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.
  • Immune responses at the site of infection (in the nasal mucosa) – essential for blocking both infection and transmission of COVID-19.

PC :https://twitter.com/BharatBiotech/photo

Related posts

Fog engulfs parts of United Arab Emirates, delaying flights

Editor

Wentz tosses for 2 TDs, leads Eagles over Redskins 28-13

Editor

Pacific Ocean Garbage Patch Growing Rapidly, Study Finds

Editor

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy